TY  - JOUR
T1  - PRostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer
AU  - Fuller DB
Y1  - 1999/05/05
N1  - 10.1001/jama.281.17.1583
JO  - JAMA
SP  - 1583
EP  - 1586
VL  - 281
IS  - 17
N2  - 
First, intermediate- to high-risk patients, as defined in this study,
had a 28% to 97% risk of having cancer cells beyond the
prostate.2 As brachytherapy could undertreat cancer cells
beyond the prostate, practitioners usually combine brachytherapy with
external beam radiation in these cases. D'Amico et al give the
potentially misleading impression that practitioners use brachytherapy
alone against intermediate- to high-risk lesions, which does not
reflect the standard practice for these patients.

SN  - 0098-7484
M3  - doi: 10.1001/jama.281.17.1583
UR  - http://dx.doi.org/10.1001/jama.281.17.1583
ER  -